1. Registered users can submit contributions to us at any time through the submission portal on the homepage or personal center. We may need some more detailed personal information when submitting.

2. We will pay no less than 10 million yuan in royalties to our authors every year, and we pay 500 to 5,000 yuan in royalties for manuscripts pushed to the homepage. Factors that determine remuneration and additional rewards include exclusive contribution, editorial evaluation, user and data feedback, etc.; our editorial department reserves the right to change and interpret terms such as calculation of remuneration and payment.

3. We will form a writers club so that our writers can meet and communicate offline.

4. The articles we hope to receive are: unique analysis or commentary on major business events; articles with forward-looking value in the macro and financial fields; exclusive business news with first-hand interviews (professional financial journalists are welcome to write for us); content related to my work that is worth sharing; very unique rankings; photo reports; original and sufficiently humorous content. Generally speaking, please keep the word count of your articles between 1,000 and 2,000 words.

5. Articles we do not recommend you send: major news reports without first-hand information or exclusive comments; articles that are offensive or infringe on other people's privacy; soft articles or articles with keyword marketing.

6. Please understand our article style and use your creativity. We hold contributors responsible for the copyright of their articles. We reserve the right to modify the title and content of the article and to add pictures to the article.

7. Articles require a certain amount of time to be reviewed, so if you think your article is very time-sensitive, please contact us via online chat or phone after submission.

8. Once an article is uploaded to us, it is deemed to be a license for us to use the work exclusively; once a non-exclusive, non-first article is uploaded to us, it is deemed to be a license for us to use it for free.

Once you submit an article to us, it will be deemed that you fully agree to accept the above content and abide by all terms.